Randomized, Double-Blind, Active Placebo-Controlled Study of Ketamine to Treat Levodopa-Induced Dyskinesia

NCT04912115 PHASE2 SUSPENDED

A Multi-Center, Phase II, Randomized, Double-Blind, Prospective, Active Placebo-Controlled Trial of Sub-Anesthetic Intravenous Infusion of Ketamine to Treat Levodopa-Induced Dyskinesia in Subjects with Parkinson's Disease.

Details

Lead sponsor	PharmaTher Inc.
Phase	PHASE2
Status	SUSPENDED
Enrolment	30
Start date	Tue Oct 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Sat Mar 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Dyskinesias
• Movement Disorders
• Central Nervous System Diseases
• Nervous System Diseases
• Neurologic Manifestations

Interventions

• Ketamine
• Midazolam

Countries

United States